For the quarter ending 2025-12-31.
| Income Statement | 2025-12-31 | 2025-09-30 | ||
|---|---|---|---|---|
| General and administrative | 1,766,210 | 2,410,516 | ||
| Research and development | 45,872 | 24,407 | ||
| Goodwill impairment | - | 0 | ||
| Long-lived asset impairment | - | 831,915 | ||
| Depreciation and amortization | 11,332 | 41,522 | ||
| Total operating expenses | 1,823,414 | 3,308,360 | ||
| Loss from operations | -1,823,414 | -3,308,360 | ||
| Change in fair value of contingent consideration | 140,000 | 370,000 | ||
| Change in fair value of equity securities | - | 156,849 | ||
| Gain on bankruptcy of subsidiary | - | 12,019,227 | ||
| Loss on extinguishment of debt | - | -6,329,592 | ||
| Interest expense | 121,508 | 122,400 | ||
| Interest income and other income (expense) | - | 33,297 | ||
| Interest and other income | 5,518 | - | ||
| Total other income (expense) | 24,010 | 6,127,381 | ||
| Net income (loss) | -1,799,404 | 2,819,021 | ||
| Basic EPS | -0.08 | 0.13 | ||
| Diluted EPS | -0.08 | 0.13 | ||
| Basic Average Shares | 23,482,714 | 22,520,245 | ||
| Diluted Average Shares | 23,482,714 | 22,520,245 | ||
Lunai Bioworks Inc. (LNAI)
Lunai Bioworks Inc. (LNAI)